Aclaris Therapeutics, Inc.【ACRS】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -917,900 +16.5%
4Q24 -902,900 +17.1%
3Q24 -806,300 +4.8%
2Q24 -798,700 +7.9%
1Q24 -787,700 +10.9%
4Q23 -770,800 +13.0%
3Q23 -769,300 +17.5%
2Q23 -740,000 +16.6%
1Q23 -710,500 +15.7%
4Q22 -682,300 +14.6%
3Q22 -654,700 +14.3%
2Q22 -634,700 +15.1%
1Q22 -614,200 +15.2%
4Q21 -595,400 +18.0%
3Q21 -572,600 +16.5%
2Q21 -551,500 +14.7%
1Q21 -533,300 +13.7%
4Q20 -504,500 +11.2%
3Q20 -491,400 +13.0%
2Q20 -480,710 +26.6%
1Q20 -469,113 +42.3%
4Q19 -453,527 +55.2%
3Q19 -434,933 +71.5%
2Q19 -379,614 +71.9%
1Q19 -329,738 +73.9%
4Q18 -292,173 +83.3%
3Q18 -253,622 +85.8%
2Q18 -220,882 +86.7%
1Q18 -189,664 +83.3%
4Q17 -159,435 +75.4%
3Q17 -136,501 +71.8%
2Q17 -118,309 +72.1%
1Q17 -103,471 +85.2%
4Q16 -90,912 +112.2%
3Q16 -79,437 -
2Q16 -68,743 -
1Q16 -55,872 -
4Q15 -42,833 -